Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

Central lipohypertrophy in HIV-infected women may lead to shorter eyelashes.

Using topical prostaglandin F2α for glaucoma may cause loss of eyelash or eyebrow pigment.

Topical prostaglandin E2 can help treat both alopecia areata and vitiligo.

Tafluprost could be a potential treatment for hair loss by promoting hair growth phase changes.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Some chemicals absorbed through the skin can cause serious health problems.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Topical finasteride reduces hair loss and promotes hair growth in men and women.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

There is an urgent need for better treatments for hair loss caused by chemotherapy.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

Eyelashes protect the eyes, but more research is needed to understand how.

Surgery may help infants with sagittal craniosynostosis develop more typical language processing.

Cosmetics and procedures can cause eye issues, from mild discomfort to serious conditions, due to allergies, toxins, or poor care.

Fractional resurfacing is safe and effective for certain skin conditions in Asian patients, but care must be taken to avoid skin pigmentation issues.

Regenerative therapies show promise for treating vitiligo and alopecia areata.